Inspiration Biopharmaceuticals Inc. reached a deal to sell its second development-stage hemophilia drug at auction to Cangene.
News & Media
Kane Biotech Inc. will launch its marketing field test for StrixNB, its revolutionary new pet oral care product, in Manitoba on February 1, 2013 in conjunction with Pet Dental Health Month
It's an undeniably great idea -- using commodities such as hemp or flax, mashed up and mixed with resin, baked and then shaped into door panels for buses or fenders for agricultural equipment or interior trim for automobiles.
The University of Manitoba is embarking on a new approach to technology commercialization.
Manitoba farmers, agriculture processors and members of the public are again encouraged to share their input to determine how Growing Forward 2 programs will be delivered, Manitoba Agriculture, Food and Rural Initiatives (MAFRI) Minister Ron Kostyshyn sai
Prime Minister Stephen Harper laid out the details Monday of a plan to bolster venture capital investment in the country.
Dr. Reno Pontarollo, the current Chief Scientific Officer of Genome Prairie, will succeed Dr. David Gauthier as President and Chief Executive Officer on April 1, 2013.
Intelligent Hospital Systems Partners with Dokuz Eylül University Hospital in Turkey to Develop Total Dose Solution
IH Systems announced a partnership with Dokuz Eylül University Hospital in Izmir, Turkey, to develop a total dose solution
Miraculins Announces PreVu® Test Expansion into Ontario and Atlantic Canada through PharmaChoice® Drug Stores
Miraculins, PharmaChoice, and Pear Healthcare Solutions announced that PharmaChoice will be the first pharmacy network to introduce the PreVu® test in Ontario and Atlantic Canada
Prairie Bio Energy Group (PBE Group) have signed a partnership with a multi-billion dollar Canadian organization, La Coop fédérée, enabling PBE Group to grow exponentially. PBE Group is approaching the point of full commercialization at their customized
Cangene and Amorfix Life Sciences established a collaboration for the identification and development of therapeutic antibodies against proprietary disease specific epitopes